Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

H1450000

(−)-scopolamina N-butilbromuro

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

(−)-N-butilscopolamina bromuro, Joscina N-butil bromuro

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali

Scegli un formato

20 MG
133,00 €

133,00 €

Per informazioni sulla disponibilità, contatta il Servizio Clienti.
Richiedi un ordine bulk
Tutte le immagini(1)

Scegli un formato

Cambia visualizzazione
20 MG
133,00 €

About This Item

Formula empirica (notazione di Hill):
C21H30BrNO4
Numero CAS:
149-64-4
Peso molecolare:
440.37
Numero MDL:
MFCD00078561
Codice UNSPSC:
41116107
ID PubChem:
329815165
NACRES:
NA.24

133,00 €

Per informazioni sulla disponibilità, contatta il Servizio Clienti.
Richiedi un ordine bulk

Grado

pharmaceutical primary standard

Famiglia di API

hyoscine

Produttore/marchio commerciale

EDQM

applicazioni

pharmaceutical (small molecule)

Formato

neat

Temperatura di conservazione

2-8°C

Stringa SMILE

[Br-].[H][C@@]12C[C@H](C[C@@]([H])([C@]3([H])O[C@]13[H])[N+]2(C)CCCC)OC(=O)[C@H](CO)c4ccccc4

InChI

1S/C21H30NO4.BrH/c1-3-4-10-22(2)17-11-15(12-18(22)20-19(17)26-20)25-21(24)16(13-23)14-8-6-5-7-9-14;/h5-9,15-20,23H,3-4,10-13H2,1-2H3;1H/q+1;/p-1/t15-,16-,17-,18+,19-,20+,22?;/m1./s1
HOZOZZFCZRXYEK-GSWUYBTGSA-M

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Hyoscine butylbromide EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

H1500000

Hyoscine hydrobromide, European Pharmacopoeia (EP) Reference Standard

Y0000483

Hyoscine, European Pharmacopoeia (EP) Reference Standard

Y0000448

Hyoscine hydrobromide impurity B, European Pharmacopoeia (EP) Reference Standard

Y0000484

Hyoscine impurity A, European Pharmacopoeia (EP) Reference Standard

1610001

Scopolamine hydrobromide, United States Pharmacopeia (USP) Reference Standard

PHR1470

Scopolamine Hydrobromide, Pharmaceutical Secondary Standard; Certified Reference Material

BP198

Joscina butilbromuro, British Pharmacopoeia (BP) Reference Standard

BP199

Hyoscine hydrobromide, British Pharmacopoeia (BP) Reference Standard

Y0001983

(−)-scopolamina N-butilbromuro, European Pharmacopoeia (EP) Reference Standard

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302 + H332

Classi di pericolo

Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 8

1 of 8

Scopolamine Hydrobromide Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1470

Scopolamine Hydrobromide

Scopolamine hydrobromide meets USP testing specifications

Sigma-Aldrich

S0929

Scopolamine hydrobromide

4-Aminoantipyrine analytical standard

Supelco

43827

4-Aminoantipyrine

Furosemide Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1057

Furosemide

(−)-Scopolamine hydrobromide trihydrate ≥98% (HPLC), powder

Sigma-Aldrich

S1875

(−)-Scopolamine hydrobromide trihydrate

Ibuprofen Related Compound C Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1146

Ibuprofen Related Compound C

Ibuprofene Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1004

Ibuprofene

Timestrip Plus™ 8 °C

Supelco

08168

Timestrip Plus™ 8 °C

Timur H Kuru et al.
Journal of computer assisted tomography, 38(4), 558-564 (2014-04-16)
To compare 2 previously presented algorithms for extracting parameters from intravoxel incoherent motion (IVIM) studies and investigate them in the context of tissue differentiation. Magnetic resonance imaging (MRI) was performed in 23 patients without histologically proven prostate carcinoma (PCa) and
K Mackway-Jones et al.
Emergency medicine journal : EMJ, 20(3), 267-267 (2003-05-16)
A short cut review was carried out to establish whether buscopan (hyoscine butylbromide) is better than analgesics at controlling pain in abdominal colic. A total of 31 papers were found using the reported search, of which none presented any evidence
Guido N Tytgat
Current medical research and opinion, 24(11), 3159-3173 (2008-10-15)
Being a quaternary ammonium compound derived from scopolamine, the alkaloid hyoscine butylbromide (HBB) exerts anticholinergic effects without side effects related to the central nervous system because it does not pass the blood-brain barrier. Clinical experience with this antispasmodic dates back
Andrew A Plumb et al.
AJR. American journal of roentgenology, 203(4), W400-W407 (2014-09-24)
The purpose of this article is to describe the MRI findings associated with lymphoid nodular hyperplasia at MR enterography and test the ability of radiologists to differentiate healthy control subjects from patients with Crohn disease (CD). Ethical approval was granted
Guido N Tytgat
Drugs, 67(9), 1343-1357 (2007-06-06)
Abdominal cramping and pain is a frequent problem in the adult population of Western countries, with an estimated prevalence of < or =30%. Hyoscine butylbromide (scopolamine butylbromide) [Buscopan/Buscapina] is an antispasmodic drug indicated for the treatment of abdominal pain associated
Visualizza tutti i documenti correlati

Domande

Recensioni

Nessuna valutazione

Filtri attivi

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.